A catheter and surgical ablation device maker working toward enabling less-invasive treatment of atrial fibrillation is looking for a big round of fresh capital for its next move. Morrisville, North Carolina, company nContact Inc. has already secured $6.7 million from a handful of investors and could continue raising up to $13 million, according a U.S. […]
"By removing 'Surgical' from our company name, we are categorically affirming our mission to transform the ablation market and change the dialogue from individual surgical or catheter approaches to interdisciplinary and [epicardial]-only approaches that may achieve greater scientific and clinical endpoints," CEO John Funkhouser said in prepared remarks.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Research Triangle Park medical device maker nContact Surgical Inc. has raised $16 million for its endoscopic cardiac ablation system that could enable doctors to treat the most difficult atrial fibrillation patients.